Your browser doesn't support javascript.
loading
CEACAM5 is an IL-13-regulated epithelial gene that mediates transcription in type-2 (T2) high severe asthma.
Mumby, Sharon; Kermani, Nazanin Zounemat; Garnett, James P; Pavlidis, Stelios; Wilson, Susan J; Howarth, Peter J; Thomas, Matthew J; Adcock, Ian M; López-García, Carlos.
Affiliation
  • Mumby S; Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, UK.
  • Kermani NZ; Department of Computing, Data Science Institute, Imperial College London, London, UK.
  • Garnett JP; Immunology and Respiratory Diseases Research, Boehringer Ingelheim Pharma GmbH and Co KG Biberach, Biberach, Germany.
  • Pavlidis S; Department of Computing, Data Science Institute, Imperial College London, London, UK.
  • Wilson SJ; Faculty of Medicine, University of Southampton, Southampton, UK.
  • Howarth PJ; Faculty of Medicine, University of Southampton, Southampton, UK.
  • Thomas MJ; Immunology and Respiratory Diseases Research, Boehringer Ingelheim Pharma GmbH and Co KG Biberach, Biberach, Germany.
  • Adcock IM; Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, UK.
  • López-García C; Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, UK.
Allergy ; 77(11): 3463-3466, 2022 11.
Article in En | MEDLINE | ID: mdl-35916059

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Interleukin-13 Limits: Humans Language: En Journal: Allergy Year: 2022 Document type: Article Affiliation country: Reino Unido Country of publication: Dinamarca

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Interleukin-13 Limits: Humans Language: En Journal: Allergy Year: 2022 Document type: Article Affiliation country: Reino Unido Country of publication: Dinamarca